Disclosed on February 7, Ronda E Stryker, Board Member at Stryker (NYSE:SYK), executed a substantial insider sell as per the latest SEC filing.
What Happened: Stryker's recent move involves selling 293,442 shares of Stryker. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value is $100,349,380.
The latest update on Thursday morning shows Stryker shares down by 0.46%, trading at $341.14.
Delving into Stryker's Background
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Understanding the Numbers: Stryker's Finances
Revenue Growth: Stryker displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 18.46%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry ...